These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 12542895)

  • 101. Simvastatin Efficiently Lowers Small LDL-IgG Immune Complex Levels: A Therapeutic Quality beyond the Lipid-Lowering Effect.
    Hörl G; Froehlich H; Ferstl U; Ledinski G; Binder J; Cvirn G; Stojakovic T; Trauner M; Koidl C; Tafeit E; Amrein K; Scharnagl H; Jürgens G; Hallström S
    PLoS One; 2016; 11(2):e0148210. PubMed ID: 26840480
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Relationship between high-density lipoprotein-cholesterol and malondialdehyde-modified low-density lipoprotein concentrations.
    Kondo A; Li J; Manabe M; Saito K; Kanno T; Maekawa M
    J Atheroscler Thromb; 2003; 10(2):72-8. PubMed ID: 12740480
    [TBL] [Abstract][Full Text] [Related]  

  • 103. Relation between antibody against oxidized low-density lipoprotein and extent of coronary atherosclerosis.
    Tsai WC; Li YH; Chao TH; Chen JH
    J Formos Med Assoc; 2002 Oct; 101(10):681-4. PubMed ID: 12517040
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Autoantibodies against oxidatively modified LDL do not constitute a risk factor for stroke: a nested case-control study.
    Ahmed E; Trifunovic J; Stegmayr B; Hallmans G; Lefvert AK
    Stroke; 1999 Dec; 30(12):2541-6. PubMed ID: 10582975
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Serum autoantibodies against human oxidized low-density lipoproteins are inversely associated with severity of coronary stenotic lesions calculated by Gensini score.
    Che J; Li G; Wang W; Li Q; Liu H; Chen K; Liu T
    Cardiol J; 2011; 18(4):364-70. PubMed ID: 21769816
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Unique antibody responses to malondialdehyde-acetaldehyde (MAA)-protein adducts predict coronary artery disease.
    Anderson DR; Duryee MJ; Shurmur SW; Um JY; Bussey WD; Hunter CD; Garvin RP; Sayles HR; Mikuls TR; Klassen LW; Thiele GM
    PLoS One; 2014; 9(9):e107440. PubMed ID: 25210746
    [TBL] [Abstract][Full Text] [Related]  

  • 107. IgM anti-malondialdehyde low density lipoprotein antibody levels indicate coronary heart disease and necrotic core characteristics in the Nordic Diltiazem (NORDIL) study and the Integrated Imaging and Biomarker Study 3 (IBIS-3).
    van den Berg VJ; Haskard DO; Fedorowski A; Hartley A; Kardys I; Caga-Anan M; Akkerhuis KM; Oemrawsingh RM; van Geuns RJ; de Jaegere P; van Mieghem N; Regar E; Ligthart JMR; Umans VAWM; Serruys PW; Melander O; Boersma E; Khamis RY
    EBioMedicine; 2018 Oct; 36():63-72. PubMed ID: 30131305
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Identification of autoantibodies in human plasma recognizing an apoB-100 LDL receptor binding site peptide.
    Fredrikson GN; Berglund G; Alm R; Nilsson JA; Shah PK; Nilsson J
    J Lipid Res; 2006 Sep; 47(9):2049-54. PubMed ID: 16809787
    [TBL] [Abstract][Full Text] [Related]  

  • 109. Polyunsaturated fatty acids acutely suppress antibodies to malondialdehyde-modified lipoproteins in patients with vascular disease.
    Gradek WQ; Harris MT; Yahia N; Davis WW; Le NA; Brown WV
    Am J Cardiol; 2004 Apr; 93(7):881-5. PubMed ID: 15050493
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Auto-antibodies against oxidized LDL as a marker of coronary artery disease in patients with familial hypercholesterolaemia.
    Paiker JE; Raal FJ; von Arb M
    Ann Clin Biochem; 2000 Mar; 37 ( Pt 2)():174-8. PubMed ID: 10735360
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Circulating autoantibodies against the apolipoprotein B-100 peptides p45 and p210 in relation to the occurrence of carotid plaques in 64-year-old women.
    Fagerberg B; Prahl Gullberg U; Alm R; Nilsson J; Fredrikson GN
    PLoS One; 2015; 10(3):e0120744. PubMed ID: 25768285
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Anti-cardiolipin, anti-endothelial-cell and anti-malondialdehyde-LDL antibodies in uremic patients undergoing hemodialysis: relationship with vascular access thrombosis and thromboembolic events.
    George J; Aron A; Levy Y; Gilburd B; Ben-David A; Renaudineau Y; Zonana-Nachach A; Youinou P; Harats D; Shoenfeld Y
    Hum Antibodies; 1999; 9(2):125-31. PubMed ID: 10405833
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Immunogenicity of oxidised low-density lipoprotein and atherosclerosis.
    Cheng HM
    S Afr Med J; 1996 Jun; 86(6):698-9. PubMed ID: 8764436
    [No Abstract]   [Full Text] [Related]  

  • 114. Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes.
    Fredrikson GN; Anand DV; Hopkins D; Corder R; Alm R; Bengtsson E; Shah PK; Lahiri A; Nilsson J
    Diabetologia; 2009 Jul; 52(7):1426-33. PubMed ID: 19448981
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Adaptive immunity is related to coronary artery disease severity after acute coronary syndrome in subjects with metabolic syndrome.
    Izar MC; Fonseca HA; Pinheiro LF; Monteiro CM; Póvoa RM; Monteiro AM; Figueiredo-Neto AM; Gidlund MA; Fonseca FA
    Diab Vasc Dis Res; 2013 Jan; 10(1):32-9. PubMed ID: 22529217
    [TBL] [Abstract][Full Text] [Related]  

  • 116. In search of biological markers of high-risk carotid artery atherosclerotic plaque: enhanced LDL oxidation.
    Chiesa R; Melissano G; Castellano R; Astore D; Marone EM; Grossi A; Maggi E; Finardi G; Casasco A; Bellomo G
    Ann Vasc Surg; 1998 Jan; 12(1):1-9. PubMed ID: 9451989
    [TBL] [Abstract][Full Text] [Related]  

  • 117. [Low concentrations of high-density lipoproteins (HDL) in plasma and coronary artery disease].
    Pérez-Méndez O; Luc G; Posadas-Romero C
    Arch Inst Cardiol Mex; 2000; 70(3):312-21. PubMed ID: 10959461
    [No Abstract]   [Full Text] [Related]  

  • 118. Plasma lipoprotein particle concentrations in postmenopausal women with unstable coronary artery disease. Analysis of diagnostic accuracy using receiver operating characteristics.
    Nielsen NE; Olsson AG; Swahn E
    J Intern Med; 2000 Jan; 247(1):43-52. PubMed ID: 10672130
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Serum lipid profile determines platelet reactivity to native and modified LDL-cholesterol in humans.
    Katzman PL; Bose R; Henry S; McLean DL; Walker S; Fyfe C; Perry Y; Mymin D; Bolli P
    Thromb Haemost; 1994 May; 71(5):627-32. PubMed ID: 8091392
    [TBL] [Abstract][Full Text] [Related]  

  • 120. Increased levels of anti-oxidized low-density lipoprotein antibodies are associated with reduced levels of cholesterol in the general population.
    Tinahones FJ; Gómez-Zumaquero JM; Rojo-Martínez G; Cardona F; Esteva de Antonio IE; Ruiz de Adana MS; Soriguer FJ
    Metabolism; 2002 Apr; 51(4):429-31. PubMed ID: 11912548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.